Reply to "Penilloate and penicilloate concentrations in practical guidance recommendations"

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1419-1420. doi: 10.1016/j.jaip.2020.11.064.

¹ IRCCS Oasi Maria S.S., Troina, Italy; Fondazione Mediterranea G.B. Morgagni, Catania, Italy.
² Division of Allergy/Immunology, Boston Children's Hospital, Boston, Mass. Electronic address: ana.broyles@childrens.harvard.edu.
³ Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
⁴ Division of Allergy and Inflammation, Beth Israel Deaconess Medical Center, Boston, Mass.
⁵ Allergy Unit and Research Group, Hospital Regional Universitario de Málaga, UMA-IBIMA-BIONAND, ARADyAL, Málaga, Spain.
⁶ Drug Hypersensitivity and Desensitization Center, Brigham and Women's Hospital, Boston, Mass.

No abstract available

Publication types